{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:20:02Z","timestamp":1793337602172,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302331"],"award-info":[{"award-number":["81302331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81320108015"],"award-info":[{"award-number":["81320108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.critrevonc.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T01:00:18Z","timestamp":1505955618000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Evolution in sentinel lymph node biopsy in breast cancer"],"prefix":"10.1016","volume":"123","author":[{"given":"Si-Qi","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien P.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gooitzen M.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2017.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00268-015-3222-2","article-title":"A comparative validation of primary surgical versus post-neo-adjuvant chemotherapy sentinel lymph node biopsy for stage III breast cancers","volume":"40","author":"Agarwal","year":"2016","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0010","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/bjs.9390","article-title":"Blue dye is sufficient for sentinel lymph node biopsy in breast cancer","volume":"101","author":"Ang","year":"2014","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1245\/s10434-015-4801-z","article-title":"Indocyanine green fluorescence for sentinel lymph node detection in early breast cancer","volume":"23","author":"Benson","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0035","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0040","article-title":"Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who received neoadjuvant chemotherapy \u2212 results from a prospective trial ACOSOG Z1071 (Alliance)","author":"Boughey","year":"2014","journal-title":"San Antonio Breast Cancer Symposium 2014"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0045","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 Trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0055","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S1470-2045(14)71018-6","article-title":"How do the AMAROS trial results change practice?","volume":"15","author":"Boughey","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1524-4741.2002.08301.x","article-title":"Consensus on sentinel node biopsy","volume":"8","author":"Cady","year":"2002","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1371\/journal.pone.0083927","article-title":"Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation","volume":"8","author":"Chi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.7150\/thno.9899","article-title":"Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology","volume":"4","author":"Chi","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0080","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0085","article-title":"Sentinel node detection after neoadjuvant chemotherapy in patient without previous axillary node involvement (GANEA 2 trial): follow-up of a prospective multi-institutional cohort","author":"Classe","year":"2016","journal-title":"San Antonio Breast Cancer Symposium 2016"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0090","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1002\/bjs.9713","article-title":"Optical innovations in surgery","volume":"102","author":"de Boer","year":"2015","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0095","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjsurg.2016.07.018","article-title":"Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients","volume":"212","author":"El Hage Chehade","year":"2016","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0115","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejso.2013.02.011","article-title":"Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy \u2212 recommendations for clinical guidance","volume":"39","author":"Fontein","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0130","doi-asserted-by":"crossref","first-page":"e105316","DOI":"10.1371\/journal.pone.0105316","article-title":"Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis","volume":"9","author":"Fu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0162605","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0145","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: S entinel node vs O bservation after axillary U ltraSou ND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","article-title":"Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial","volume":"16","author":"Gill","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized t","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1477-7819-12-290","article-title":"Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer","volume":"12","author":"Guo","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0175","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s13277-013-1399-2","article-title":"Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye","volume":"35","author":"Guo","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0180","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0185","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1245\/s10434-012-2478-0","article-title":"A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients","volume":"19","author":"Hirano","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0190","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12282-014-0573-8","article-title":"Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer","volume":"23","author":"Inoue","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0200","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/S1470-2045(16)30311-4","article-title":"De-escalation of axillary surgery in early breast cancer","volume":"17","author":"Jatoi","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0205","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/his.12019","article-title":"Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection","volume":"62","author":"Johnson","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0210","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1245\/s10434-013-3437-0","article-title":"Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial","volume":"21","author":"Jung","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejso.2014.10.066","article-title":"A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer","volume":"41","author":"Kida","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2325\/jbcs.12.211","article-title":"Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer","volume":"12","author":"Kitai","year":"2005","journal-title":"Breast Cancer"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0225","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0240","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00268-010-0683-1","article-title":"Is breast cancer the same disease in Asian and Western countries?","volume":"34","author":"Leong","year":"2010","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12893-015-0067-4","article-title":"Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer","volume":"15","author":"Li","year":"2015","journal-title":"BMC Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0250","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0255","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0260","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","author":"Lyman","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0265","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast Cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0275","article-title":"Changing paradigms in the local therapy of breast cancer: making less more","author":"Morrow","year":"2016","journal-title":"San Antonio Breast Cancer Symposium 2016"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0280","series-title":"Breast Cancer (Version 2.2016)","author":"National Comprehensive Cancer Network","year":"2016"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0285","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0002-9394(14)72554-1","article-title":"Survey of complications of indocyanine green angiography in Japan","volume":"118","author":"Obana","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0290","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"20","author":"Park","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","article-title":"Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy","volume":"16","author":"Rescigno","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejso.2014.10.047","article-title":"The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study","volume":"41","author":"Samorani","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0305","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0310","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-109-4-345_2","article-title":"Anaphylactoid reactions after indocyanine-green administration","volume":"109","author":"Speich","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0315","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","article-title":"Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer","volume":"28","author":"Straver","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1245\/s10434-015-4809-4","article-title":"Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer","volume":"23","author":"Sugie","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-015-3542-9","article-title":"Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer","volume":"153","author":"Toh","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0330","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4048\/jbc.2014.17.3.250","article-title":"Use of fluorescence imaging in combination with patent blue dye versus patent blue dye alone in sentinel lymph node biopsy in breast cancer","volume":"17","author":"Tong","year":"2014","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0335","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.breast.2015.02.034","article-title":"Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: usefulness of the indocyanine green-fluorescence method","volume":"24","author":"Tsuyuki","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0340","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","article-title":"The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"41","author":"van Nijnatten","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0345","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0350","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2015.03.014","article-title":"Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: identification rate and influence on axillary treatment","volume":"51","author":"Van Der Heiden-Van Der Loo","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0355","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-013-2802-9","article-title":"Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience","volume":"143","author":"Verbeek","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0360","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0365","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","article-title":"Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study","volume":"7","author":"Veronesi","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0370","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","article-title":"Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study","volume":"7","author":"Veronesi","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0375","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0380","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1148\/radiology.175.2.2326475","article-title":"Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging","volume":"175","author":"Weissleder","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0385","first-page":"17","article-title":"Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial","volume":"22","author":"Wetzig","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0390","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/bjs.10283","article-title":"Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique","volume":"103","author":"Zada","year":"2016","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2017.09.010_bib0395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","article-title":"A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial","volume":"247","author":"Zavagno","year":"2008","journal-title":"Ann. Surg."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:36:51Z","timestamp":1778794611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817300355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":79,"alternative-id":["S1040842817300355"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.09.010","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution in sentinel lymph node biopsy in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}